Impact of FOXA1 Expression on the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer

被引:0
|
作者
Yuichi Hisamatsu
Eriko Tokunaga
Nami Yamashita
Sayuri Akiyoshi
Satoko Okada
Yuichiro Nakashima
Shinichi Aishima
Masaru Morita
Yoshihiro Kakeji
Yoshihiko Maehara
机构
[1] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
[2] Kyushu University,Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences
来源
关键词
Breast Cancer; Estrogen Receptor; Hormone Therapy; Progesterone Receptor; Ki67 Index;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1145 / 1152
页数:7
相关论文
共 50 条
  • [1] Impact of FOXA1 Expression on the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer
    Hisamatsu, Yuichi
    Tokunaga, Eriko
    Yamashita, Nami
    Akiyoshi, Sayuri
    Okada, Satoko
    Nakashima, Yuichiro
    Aishima, Shinichi
    Morita, Masaru
    Kakeji, Yoshihiro
    Maehara, Yoshihiko
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (04) : 1145 - 1152
  • [2] Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer
    Hisamatsu, Yuichi
    Tokunaga, Eriko
    Yamashita, Nami
    Akiyoshi, Sayuri
    Okada, Satoko
    Nakashima, Yuichiro
    Taketani, Kenji
    Aishima, Shinichi
    Oda, Yoshinao
    Morita, Masaru
    Maehara, Yoshihiko
    BREAST CANCER, 2015, 22 (05) : 520 - 528
  • [3] Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer
    Yuichi Hisamatsu
    Eriko Tokunaga
    Nami Yamashita
    Sayuri Akiyoshi
    Satoko Okada
    Yuichiro Nakashima
    Kenji Taketani
    Shinichi Aishima
    Yoshinao Oda
    Masaru Morita
    Yoshihiko Maehara
    Breast Cancer, 2015, 22 : 520 - 528
  • [4] FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients
    Chenpu Xu
    Qun Wei
    Jufeng Guo
    Ji Chun Zhou
    Jin Mei
    Zhi Nong Jiang
    Jian Guo Shen
    Lin Bo Wang
    Annals of Surgical Oncology, 2015, 22 : 2034 - 2039
  • [5] FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients
    Xu, Chenpu
    Wei, Qun
    Guo, Jufeng
    Zhou, Ji Chun
    Mei, Jin
    Jiang, Zhi Nong
    Shen, Jian Guo
    Wang, Lin Bo
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (06) : 2034 - 2039
  • [6] FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer
    Kawase, Mai
    Toyama, Tatsuya
    Takahashi, Satoru
    Sato, Shinya
    Yoshimoto, Nobuyasu
    Endo, Yumi
    Asano, Tomoko
    Kobayashi, Shunzo
    Fujii, Yoshitaka
    Yamashita, Hiroko
    BREAST CANCER, 2015, 22 (03) : 308 - 316
  • [7] FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer
    Mai Kawase
    Tatsuya Toyama
    Satoru Takahashi
    Shinya Sato
    Nobuyasu Yoshimoto
    Yumi Endo
    Tomoko Asano
    Shunzo Kobayashi
    Yoshitaka Fujii
    Hiroko Yamashita
    Breast Cancer, 2015, 22 : 308 - 316
  • [8] Targeting FoxA1 in estrogen receptor-positive breast cancer: biological characterization of kinase regulators
    Johnston, Simon J.
    Holmes, Kelly A.
    Carroll, Jason S.
    CANCER RESEARCH, 2016, 76
  • [9] FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
    Nelson Rangel
    Nicoletta Fortunati
    Simona Osella-Abate
    Laura Annaratone
    Claudio Isella
    Maria Graziella Catalano
    Letizia Rinella
    Jasna Metovic
    Renzo Boldorini
    Davide Balmativola
    Pietro Ferrando
    Francesca Marano
    Paola Cassoni
    Anna Sapino
    Isabella Castellano
    BMC Cancer, 18
  • [10] FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
    Rangel, Nelson
    Fortunati, Nicoletta
    Osella-Abate, Simona
    Annaratone, Laura
    Isella, Claudio
    Catalano, Maria Graziella
    Rinella, Letizia
    Metovic, Jasna
    Boldorini, Renzo
    Balmativola, Davide
    Ferrando, Pietro
    Marano, Francesca
    Cassoni, Paola
    Sapino, Anna
    Castellano, Isabella
    BMC CANCER, 2018, 18